IGC Pharma IncIGC
Price$0.27Intrinsic value$0.3633% above price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $0.36median of 2 methodsbased on filings through 30 Jun 2026
Market Price $0.27Price as of 1 Oct 2026
Margin of Safety +32.5%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Discount rate (cost of equity) 7.9%
Volatility vs market (adjusted beta)0.65

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetIGC Pharma IncIGCHealth Care
Valuation
P/E—
P/S28.1×
P/B17.3×
EV / Revenue27.9×
EV / EBITDA—
Profitability
Gross margin17.3%
Operating margin-775.4%
Net margin-757.7%
FCF margin-537.2%
Returns
ROE-105.2%
ROA-67.9%
ROIC—
Growth
Revenue growth (YoY)-3.9%
5-yr fwd EPS growth—
Financial strength
Debt / Equity0.02×
Current ratio0.39×
Altman Z-Score-15.0
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.